News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection
16 Sep 2022
byStephen Padilla
Treatment with vebicorvir (VBR) plus nucleos(t)ide reverse transcriptase inhibitors (NrtIs) among virologically suppressed patients with chronic hepatitis B virus (HBV) is well tolerated and has a favourable safety profile, according to a 24-week study.
16 Sep 2022

Nirmatrelvir conferred protection in older adults during the Omicron outbreak
13 Sep 2022
byElaine Soliven
During the surge of the Omicron (B.1.1.529) variant, antiviral therapy with nirmatrelvir significantly reduced the rate of COVID-19-related hospitalization or death among patients aged ≥65 years, according to a recent study.
13 Sep 2022






